Ratings by Raymond James (Steven Seedhouse)

Date CompanySymbol Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
9/14/2021 Jounce Therapeutics JNCE Upgrade Outperform
(Market Perform)
6.35
(7.79)
22.68% Details
9/13/2021 NGM Biopharmaceuticals NGM Upgrade Strong Buy
(Outperform)
21.25
(23.03)
8.38% Details
9/8/2021 Kadmon Holdings KDMN Downgrade Market Perform
(Outperform)
5.30
(8.73)
64.72% Details
8/12/2021 Arcturus Therapeutics ARCT Downgrade Underperform
(Market Perform)
50.58
(54.45)
7.65% Details
8/10/2021 Apellis Pharmaceuticals APLS Maintain Strong Buy
(N/A)
 
 
  Details
7/30/2021 Landos Biopharma LABP Maintain Outperform
(N/A)
 
 
  Details
6/29/2021 Intellia Therapeutics NTLA Maintain Outperform
(N/A)
 
 
  Details
6/7/2021 Biogen BIIB Upgrade Market Perform
(Underperform)
286.14
(300.19)
4.91% Details
5/24/2021 NGM Biopharmaceuticals NGM Downgrade Outperform
(Strong Buy)
28.38
(21.25)
-25.12% Details
5/13/2021 Inflarx NV IFRX Maintain Outperform
(N/A)
 
 
  Details
5/7/2021 ChemoCentryx CCXI Downgrade Outperform
(Strong Buy)
27.49
(16.57)
-39.72% Details
5/7/2021 Intercept Pharmaceuticals ICPT Maintain Outperform
(N/A)
 
 
  Details
3/25/2021 Inflarx NV IFRX Maintain Outperform
(N/A)
 
 
  Details
3/5/2021 NGM Biopharmaceuticals NGM Maintain Strong Buy
(N/A)
 
 
  Details
3/5/2021 Kadmon Holdings KDMN Maintain Outperform
(N/A)
 
 
  Details
3/2/2021 ChemoCentryx CCXI Maintain Strong Buy
(N/A)
 
 
  Details
3/1/2021 Landos Biopharma LABP New Coverage Outperform
(N/A)
12.99
(15.54)
19.63% Details
2/26/2021 Intercept Pharmaceuticals ICPT Maintain Outperform
(N/A)
 
 
  Details
2/26/2021 Editas Medicine EDIT Maintain Market Perform
(N/A)
 
 
  Details
1/11/2021 Gilead Sciences GILD Maintain Market Perform
(N/A)
 
 
  Details
1/7/2021 Alexion Pharmaceuticals ALXN Downgrade Market Perform
(Outperform)
157.76
(182.01)
15.37% Details
1/7/2021 Editas Medicine EDIT Downgrade Market Perform
(Outperform)
80.54
(63.20)
-21.53% Details
12/29/2020 Arcturus Therapeutics ARCT Downgrade Market Perform
(Outperform)
98.13
(54.45)
-44.51% Details
11/13/2020 Mirum Pharamceuticals MIRM Maintain Strong Buy
(N/A)
 
 
  Details
11/10/2020 Arcturus Therapeutics ARCT Maintain Outperform
(N/A)
 
 
  Details
11/10/2020 Intercept Pharmaceuticals ICPT Upgrade Outperform
(Market Perform)
28.15
(15.93)
-43.41% Details
11/6/2020 Kadmon Holdings KDMN Maintain Outperform
(N/A)
 
 
  Details
11/6/2020 Editas Medicine EDIT Maintain Outperform
(N/A)
 
 
  Details
11/6/2020 CymaBay Therapeutic CBAY Maintain Strong Buy
(N/A)
 
 
  Details
11/5/2020 Intellia Therapeutics NTLA Maintain Outperform
(N/A)
 
 
  Details
11/2/2020 Jounce Therapeutics JNCE Downgrade Market Perform
(Strong Buy)
8.32
(7.79)
-6.37% Details
10/29/2020 Alexion Pharmaceuticals ALXN Maintain Outperform
(N/A)
 
 
  Details
10/27/2020 Apellis Pharmaceuticals APLS Maintain Strong Buy
(N/A)
 
 
  Details
10/19/2020 89bio Inc. ETNB New Coverage Strong Buy
(N/A)
23.73
(21.31)
-10.2% Details
9/9/2020 Mirum Pharamceuticals MIRM Maintain Strong Buy
(N/A)
 
 
  Details
8/27/2020 VBI Vaccines VBIV Upgrade Strong Buy
(Outperform)
3.28
(3.31)
0.91% Details
8/11/2020 CymaBay Therapeutic CBAY Maintain Strong Buy
(N/A)
 
 
  Details
8/11/2020 ChemoCentryx CCXI Maintain Strong Buy
(N/A)
 
 
  Details
8/11/2020 Arcturus Therapeutics ARCT Maintain Outperform
(N/A)
 
 
  Details
8/7/2020 Kadmon Holdings KDMN Maintain Outperform
(N/A)
 
 
  Details
8/7/2020 Editas Medicine EDIT Maintain Outperform
(N/A)
 
 
  Details
8/7/2020 Mirum Pharamceuticals MIRM Upgrade Strong Buy
(Outperform)
22.37
(18.08)
-19.18% Details
8/7/2020 Mimecast Limited MIME Upgrade Strong Buy
(Outperform)
45.97
(67.41)
46.64% Details
7/31/2020 Inflarx NV IFRX Maintain Outperform
(N/A)
 
 
  Details
7/31/2020 Alexion Pharmaceuticals ALXN Maintain Outperform
(N/A)
 
 
  Details
7/24/2020 Arcturus Therapeutics ARCT Maintain Outperform
(N/A)
 
 
  Details
7/23/2020 CymaBay Therapeutic CBAY Upgrade Strong Buy
(Outperform)
3.51
(3.82)
8.83% Details
7/22/2020 VBI Vaccines VBIV Maintain Outperform
(N/A)
 
 
  Details
7/16/2020 Arcturus Therapeutics ARCT New Coverage Outperform
(N/A)
54.00
(54.45)
0.83% Details
6/17/2020 Inflarx NV IFRX Maintain Outperform
(N/A)
 
 
  Details
5/22/2020 Intercept Pharmaceuticals ICPT Downgrade Outperform
(Strong Buy)
91.69
(15.93)
-82.63% Details
5/21/2020 Inflarx NV IFRX Maintain Outperform
(N/A)
 
 
  Details
5/21/2020 Kadmon Holdings KDMN Maintain Outperform
(N/A)
 
 
  Details
5/19/2020 Kadmon Holdings KDMN New Coverage Outperform
(N/A)
4.42
(5.30)
19.91% Details
5/18/2020 ChemoCentryx CCXI Maintain Strong Buy
(N/A)
 
 
  Details
5/15/2020 Galmed Pharmaceuticals GLMD Maintain Outperform
(N/A)
 
 
  Details
5/14/2020 NGM Biopharmaceuticals NGM Maintain Strong Buy
(N/A)
 
 
  Details
5/12/2020 ChemoCentryx CCXI Maintain Strong Buy
(N/A)
 
 
  Details
5/12/2020 CymaBay Therapeutic CBAY Upgrade Outperform
(Market Perform)
1.78
(3.51)
97.19% Details
5/8/2020 Mirum Pharamceuticals MIRM Maintain Outperform
(N/A)
 
 
  Details
5/1/2020 Gilead Sciences GILD Downgrade Market Perform
(Outperform)
83.14
(71.61)
-13.87% Details
4/30/2020 Inflarx NV IFRX Upgrade Outperform
(Market Perform)
5.80
(2.73)
-52.93% Details
4/29/2020 Gilead Sciences GILD Maintain Outperform
(N/A)
 
 
  Details
4/23/2020 Gilead Sciences GILD Maintain Outperform
(N/A)
 
 
  Details
4/17/2020 Gilead Sciences GILD Maintain Outperform
(N/A)
 
 
  Details
4/6/2020 NGM Biopharmaceuticals NGM New Coverage Strong Buy
(N/A)
12.45
(28.38)
127.95% Details
4/1/2020 Apellis Pharmaceuticals APLS New Coverage Strong Buy
(N/A)
28.68
(34.21)
19.28% Details
3/25/2020 Jounce Therapeutics JNCE Upgrade Strong Buy
(Outperform)
4.33
(8.32)
92.15% Details
3/13/2020 Mirum Pharamceuticals MIRM Maintain Outperform
(N/A)
 
 
  Details
3/13/2020 Bellicum Pharmaceuticals BLCM Maintain Outperform
(N/A)
 
 
  Details
3/11/2020 ChemoCentryx CCXI Maintain Strong Buy
(N/A)
 
 
  Details
2/27/2020 Editas Medicine EDIT Maintain Outperform
(N/A)
 
 
  Details
2/5/2020 Gilead Sciences GILD Downgrade Outperform
(Strong Buy)
66.36
(71.61)
7.91% Details
1/31/2020 Alexion Pharmaceuticals ALXN Maintain Outperform
(N/A)
 
 
  Details
1/15/2020 Alexion Pharmaceuticals ALXN Maintain Outperform
(N/A)
 
 
  Details
1/8/2020 Alexion Pharmaceuticals ALXN Maintain Outperform
(N/A)
 
 
  Details
12/3/2019 Audentes Therapeutics BOLD Downgrade Market Perform
(Outperform)
28.61
(59.97)
109.61% Details
11/26/2019 ChemoCentryx CCXI Maintain Strong Buy
(N/A)
 
 
  Details
11/26/2019 CymaBay Therapeutic CBAY Downgrade Market Perform
(Strong Buy)
5.55
(3.82)
-31.17% Details
11/14/2019 VBI Vaccines VBIV New Coverage Outperform
(N/A)
0.56
(3.28)
485.71% Details
11/1/2019 Intellia Therapeutics NTLA Upgrade Outperform
(Market Perform)
11.77
(157.29)
1236.36% Details
10/25/2019 Gilead Sciences GILD Maintain Strong Buy
(N/A)
 
 
  Details
10/21/2019 Intercept Pharmaceuticals ICPT Maintain Strong Buy
(N/A)
 
 
  Details
8/30/2019 Alexion Pharmaceuticals ALXN Maintain Outperform
(N/A)
 
 
  Details
8/23/2019 Intercept Pharmaceuticals ICPT Maintain Strong Buy
(N/A)
 
 
  Details
8/23/2019 Gilead Sciences GILD Maintain Strong Buy
(N/A)
 
 
  Details
8/12/2019 Mirum Pharamceuticals MIRM New Coverage Outperform
(N/A)
14.77
(18.08)
22.41% Details
8/7/2019 Intercept Pharmaceuticals ICPT Maintain Strong Buy
(N/A)
 
 
  Details
7/31/2019 Gilead Sciences GILD Maintain Strong Buy
(N/A)
 
 
  Details
7/29/2019 Bellicum Pharmaceuticals BLCM New Coverage Outperform
(N/A)
1.47
(3.15)
114.29% Details
7/29/2019 Audentes Therapeutics BOLD New Coverage Outperform
(N/A)
38.57
(28.61)
-25.82% Details
7/29/2019 Ra Pharma RARX Downgrade Market Perform
(Strong Buy)
35.96
(48.00)
33.48% Details
7/23/2019 Intercept Pharmaceuticals ICPT Maintain Strong Buy
(N/A)
 
 
  Details
7/23/2019 Editas Medicine EDIT Maintain Outperform
(N/A)
 
 
  Details
6/26/2019 Biogen BIIB Maintain Market Perform
(N/A)
 
 
  Details
6/25/2019 Acer Therapeutics ACER Downgrade Market Perform
(Outperform)
19.28
(2.46)
-87.24% Details
6/12/2019 CymaBay Therapeutic CBAY Upgrade Strong Buy
(Outperform)
11.09
(3.82)
-65.55% Details
6/6/2019 Intercept Pharmaceuticals ICPT Maintain Strong Buy
(N/A)
 
 
  Details
6/5/2019 Inflarx NV IFRX Downgrade Market Perform
(Outperform)
37.29
(2.73)
-92.68% Details
5/29/2019 CymaBay Therapeutic CBAY Maintain Outperform
(N/A)
 
 
  Details
5/24/2019 Inflarx NV IFRX Maintain Outperform
(N/A)
 
 
  Details
5/10/2019 Ra Pharma RARX Maintain Strong Buy
(N/A)
 
 
  Details
5/9/2019 CymaBay Therapeutic CBAY Maintain Outperform
(N/A)
 
 
  Details
5/7/2019 ChemoCentryx CCXI Maintain Strong Buy
(N/A)
 
 
  Details
5/3/2019 Gilead Sciences GILD Maintain Strong Buy
(N/A)
 
 
  Details
4/26/2019 Alexion Pharmaceuticals ALXN Maintain Outperform
(N/A)
 
 
  Details
4/23/2019 Gilead Sciences GILD Maintain Strong Buy
(N/A)
 
 
  Details
4/23/2019 ChemoCentryx CCXI Maintain Strong Buy
(N/A)
 
 
  Details
4/23/2019 CymaBay Therapeutic CBAY Maintain Outperform
(N/A)
 
 
  Details
4/10/2019 Ra Pharma RARX Maintain Outperform
(N/A)
 
 
  Details
4/10/2019 Alexion Pharmaceuticals ALXN New Coverage Outperform
(N/A)
139.75
(182.01)
30.24% Details
4/10/2019 Biogen BIIB New Coverage Market Perform
(N/A)
239.74
(329.01)
37.24% Details
3/8/2019 Ra Pharma RARX Maintain Strong Buy
(N/A)
 
 
  Details
2/28/2019 Intercept Pharmaceuticals ICPT Maintain Strong Buy
(N/A)
 
 
  Details
2/15/2019 Acer Therapeutics ACER New Coverage Outperform
(N/A)
24.35
(19.28)
-20.82% Details
2/12/2019 Gilead Sciences GILD Maintain Strong Buy
(N/A)
 
 
  Details
2/5/2019 Gilead Sciences GILD Maintain Strong Buy
(N/A)
 
 
  Details
2/4/2019 Intercept Pharmaceuticals ICPT Upgrade Strong Buy
(Outperform)
116.62
(91.69)
-21.38% Details
1/24/2019 Gilead Sciences GILD Maintain Strong Buy
(N/A)
 
 
  Details
10/2/2018 Intercept Pharmaceuticals ICPT Downgrade Outperform
(Strong Buy)
126.36
(116.62)
-7.71% Details